A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia
Clinical trial NCT02627677 · TERMINATED
Trial details
- NCT number
- NCT02627677
- Sponsor
- Ariad Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-31
- Primary completion
- 2020-10-29
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.